Several factors affect the prognosis of the breast cancer, including clinicopathological features (such as patient age, lymph node status, tumor size, etc.)and molecular biology parameters (such as hormonal receptors, human epidermal growth factor receptor 2 (HER2) and molecular subtype) [3]. Here, ERBB2 is linked to breast cancer.